Alignment Healthcare (ALHC) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
9 Jul, 2026Executive summary
Health plan membership grew 56.1% year-over-year to 175,100 as of June 30, 2024, surpassing guidance and making the company one of the fastest-growing Medicare Advantage plans nationally, driven by expansion across 53 markets in 6 states.
Total revenue for Q2 2024 reached $681.3 million, a 47.3% increase year-over-year, reflecting strong membership growth.
Adjusted EBITDA was $6.0 million, at the high end of guidance and positive for the quarter, while net loss improved to $24.0 million from $28.5 million year-over-year.
Investments in member experience, technology, clinical infrastructure, and data platforms have driven growth and improved retention, with voluntary disenrollment rates improving by 22% year-over-year.
The company is focused on profitable growth, leveraging operational visibility and control to manage MBR and scale efficiently.
Financial highlights
Q2 2024 revenue was $681.3 million, up 47.3% year-over-year; revenue excluding ACO REACH was $682.0 million, up 57.8%.
Adjusted gross profit was $77 million; MBR of 88.7%, a 220 basis point improvement from Q1.
Adjusted EBITDA was $6.0 million, compared to $(2.1) million in Q2 2023; net loss was $(24.0) million, improved from $(28.5) million year-over-year.
SG&A was $88 million; adjusted SG&A $71 million, up 27% year-over-year; adjusted SG&A as % of revenue (ex-ACO REACH) improved by 250 basis points to 10.4%.
Cash, cash equivalents, and short-term investments totaled $363.7 million as of June 30, 2024.
Outlook and guidance
Q3 2024: Membership expected at 176,000–178,000; revenue $655M–$665M; adjusted gross profit $75M–$81M; adjusted EBITDA $0–$12M.
Full year 2024: Membership 178,000–180,000; revenue $2.61B–$2.64B; adjusted gross profit $280M–$310M; adjusted EBITDA -$12M to $12M.
Year-end membership guidance raised by 8,000 due to outperformance; midpoint of membership guidance up 16,000 since January.
2025 targets: At least 20% growth in both membership and revenue, with margin expansion and adjusted EBITDA profitability.
Liquidity is expected to be sufficient to fund operations and capital needs for at least the next 12 months.
Latest events from Alignment Healthcare
- Q1 2025 revenue rose 47.5% with higher guidance, margin gains, and a CFO transition.ALHC
Q1 20258 Jul 2026 - Data-driven care and operational discipline fuel growth, with stable outlook and expanding markets.ALHC
Goldman Sachs 47th Annual Global Healthcare Conference 202610 Jun 2026 - Stable trends, tech-driven growth, and expanding margins drive strong outlook and scalability.ALHC
Bank of America Global Healthcare Conference 202613 May 2026 - Leadership structure updated with new Chair, Vice Chair, and executive appointments.ALHC
Proxy filing12 May 2026 - Revenue up 33%, net income positive, and margin expansion drives strong Q1 results.ALHC
Q1 20265 May 2026 - Board recommends approval of all proposals amid strong growth, governance, and ESG focus.ALHC
Proxy filing24 Apr 2026 - Virtual meeting to vote on directors, auditor, and executive pay, with board support for all.ALHC
Proxy filing24 Apr 2026 - Disciplined growth, robust retention, and scalable care models drive strong performance.ALHC
Leerink Global Healthcare Conference 202610 Mar 2026 - 2025 revenue rose 46% with margin gains; 2026 guidance signals strong growth and cash flow.ALHC
Q4 202527 Feb 2026